Your session is about to expire
← Back to Search
Hyperpolarized Carbon-13 Pyruvate Imaging for Traumatic Brain Injury (HPTBI Trial)
HPTBI Trial Summary
This trial is testing a new imaging agent to see if it can detect changes in brain metabolism after traumatic brain injury.
HPTBI Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHPTBI Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HPTBI Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My traumatic brain injury happened less than 30 days ago.I do not have a major neurological condition that would stop me from following the study's requirements.You have a non-injury-related abnormality in your brain found on a head CT scan.You have a documented and confirmed traumatic brain injury with a Glasgow Coma Scale score of 10-15 or loss of consciousness for more than 10 minutes.I am between 18 and 60 years old.You have severe injuries from a major accident that could make it difficult to track your progress and evaluate the results of the study.You have severe mental health conditions like schizophrenia or bipolar disorder that could make it hard for you to follow the study rules.You have used illegal drugs like cocaine, LSD, or marijuana that can affect your brain function before the MRI/MRSI scan.You have metal objects in your head that could cause problems during an MRI scan.My brain scan shows significant changes, like bleeding or swelling.You need to have a head CT scan when you are admitted to the study.I have had a penetrating brain injury.
- Group 1: Hyperpolarized [1-13C] Pyruvate
- Group 2: Hyperpolarized [2-13C] Pyruvate
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are applicants aged 70 or younger qualified for this research trial?
"The eligibility requirements for enrolment in this clinical trial necessitates that applicants are aged between 18 and 60. Separately, there exist 157 trials for minors and 706 studies dedicated to those over the retirement age of 65."
Are there still opportunities for volunteer participants?
"According to the details recorded on clinicaltrials.gov, this investigation has ended its recruitment phase which began June 1st 2018 and concluded September 28th 2022. Fortunately, there are 906 other trials actively seeking participants at this time."
Is there a possibility to participate in this research initiative?
"This study is seeking a total of 60 volunteers aged between 18 and 60 who have suffered from brain trauma. To be considered, potential participants must meet these requirements."
Share this study with friends
Copy Link
Messenger